Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
Comparison of Aerosolized Swallowed Fluticasone to Esomeprazole for the Treatment of Eosinophilic Esophagitis
Status: Archived
mi
from
Washington,
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
Comparison of Aerosolized Swallowed Fluticasone to Esomeprazole for the Treatment of Eosinophilic Esophagitis
Status: Archived
Updated: 1/1/1970
Walter Reed Army Medical Center
mi
from
Washington,
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Montgomery, AL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Institute for Advanced Wound Care
mi
from
Montgomery, AL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Tucson, AZ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University of Arizona College of Medicine
mi
from
Tucson, AZ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Castro Valley, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Center for Clinical Research
mi
from
Castro Valley, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Encinitas, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
ILD Consulting, Inc.
mi
from
Encinitas, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Los Angeles, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Vascular Surgery Associates
mi
from
Los Angeles, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
San Diego, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Miami, FL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
mi
from
Miami, FL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Portland, OR
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Doernbecher Children's Hospital
mi
from
Portland, OR
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Tamarac, FL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Dr. Robert Snyder
mi
from
Tamarac, FL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Chicago, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Jacksonville, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Passavant Area Hospital
mi
from
Jacksonville, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
North Chicago, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Rosalind Franklin University
mi
from
North Chicago, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Springfield, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Southern Ilinois University School of Medicine
mi
from
Springfield, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Des Moines, IA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Broadlawns Medical Center
mi
from
Des Moines, IA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Baltimore, MD
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Johns Hopkins Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Boston, MA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Boston, MA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Stoughton, MA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
New England Sinai Hospital
mi
from
Stoughton, MA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Las Vegas, NV
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Emerson, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Vincent Giacalone
mi
from
Emerson, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
New York, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Summit, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Overglook Hospital Wound Healing Program
mi
from
Summit, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Chapel Hill, NC
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Harrisburg, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Reading, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Center for Advanced Wound Care
mi
from
Reading, PA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Arlington, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Arlington Research Center
mi
from
Arlington, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Dallas, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Wound Care Consultants
mi
from
Dallas, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Houston, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Lubbock, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
San Antonio, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Peripheral Vascular Associates
mi
from
San Antonio, TX
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Salt Lake City, UT
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
University Of Utah Hospital
mi
from
Salt Lake City, UT
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Englewood, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Libertyville, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Lake Shore Pediatrics
mi
from
Libertyville, IL
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
mi
from
Spokane, WA
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Providence Sacred Heart
mi
from
Spokane, WA
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
mi
from
Houston, TX
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
mi
from
Houston, TX
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
Updated: 1/1/1970
Ben Taub General Hospital
mi
from
Houston, TX
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
mi
from
East Orange, NJ
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
mi
from
Duarte, CA
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
Updated: 1/1/1970
City of Hope National Medical Center
mi
from
Duarte, CA
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
mi
from
Los Angeles, CA
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
Updated: 1/1/1970
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
mi
from
Houston, TX
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Enhancing Detection of Small Esophageal Varices by PillCam ESO
A New Technique to Enhance Detection of Small Esophageal Varices by PillCam ESO Capsule Endoscopy
Status: Archived
mi
from
Milwaukee, WI
Enhancing Detection of Small Esophageal Varices by PillCam ESO
A New Technique to Enhance Detection of Small Esophageal Varices by PillCam ESO Capsule Endoscopy
Status: Archived
Updated: 1/1/1970
Froedtert Memorial Luthern Hospital
mi
from
Milwaukee, WI
Effect of Vitamin D3 on Vascular Function
The Effect of Cholecalciferol (Vitamin D3) on Vascular Function and Cardiovascular Risk Factors
Status: Archived
mi
from
Los Angeles, CA
Effect of Vitamin D3 on Vascular Function
The Effect of Cholecalciferol (Vitamin D3) on Vascular Function and Cardiovascular Risk Factors
Status: Archived
Updated: 1/1/1970
Charles R. Drew University of Medicine and Science
mi
from
Los Angeles, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
Phoenix, AZ
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
HOPE Research Institute
mi
from
Phoenix, AZ
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
Tucson, AZ
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
Southern Arizona Limb Salvage Alliance (SALSA)
mi
from
Tucson, AZ
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
Winston-Salem, NC
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
The Center for Clinical Research
mi
from
Winston-Salem, NC
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
Fresno, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
Jay Mukker, DPM Inc.
mi
from
Fresno, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
Poway, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
Palomar Pomerado Health Wound Care Center
mi
from
Poway, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
San Jose, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
O'Connor Wound Care Clinic
mi
from
San Jose, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
mi
from
Walnut Creek, CA
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
John Muir Wound Care Center
mi
from
Walnut Creek, CA